Search Results - "Zeuner, Rainald A"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1
  2. 2

    Differential signaling by CpG DNA in DCs and B cells: not just TLR9 by Verthelyi, Daniela, Zeuner, Rainald A

    Published in Trends in immunology (01-10-2003)
    “…CpG-containing oligodeoxynucleotides (CpG ODNs) act on Toll-like receptor 9 (TLR9) that is expressed on B cells and plasmacytoid dendritic cells (pDCs) to…”
    Get full text
    Journal Article
  3. 3

    FabryScan: a screening tool for early detection of Fabry disease by Arning, Kathrin, Naleschinski, Dennis, Maag, Rainer, Biegstraaten, Marieke, Kropp, Peter, Lorenzen, Jürgen, Hollak, Carla E. M., van Schaik, Ivo N., Harten, Pontus, Zeuner, Rainald A., Binder, Andreas, Baron, Ralf

    Published in Journal of neurology (01-11-2012)
    “…Fabry disease, an X-linked lipid storage disorder, is associated early morbidity and mortality. Since enzyme replacement therapy is available, accurate…”
    Get full text
    Journal Article
  4. 4

    One Foot Away by Zeuner, Rainald A

    Published in The New England journal of medicine (28-11-2002)
    “…To the Editor: The patient with systemic lupus erythematosus and tuberculosis described in the Clinical Problem-Solving article by Haberer et al. (May 2 issue)…”
    Get full text
    Journal Article
  5. 5

    Reduction of CpG‐induced arthritis by suppressive oligodeoxynucleotides by Zeuner, Rainald A., Ishii, Ken J., Lizak, Martin J., Gursel, Ihsan, Yamada, Hiroshi, Klinman, Dennis M., Verthelyi, Daniela

    Published in Arthritis and rheumatism (01-08-2002)
    “…Objective Bacterial DNA contains immunostimulatory CpG motifs that cause inflammation when injected into the knee joints of normal mice. We examined whether…”
    Get full text
    Journal Article
  6. 6

    Influence of stimulatory and suppressive DNA motifs on host susceptibility to inflammatory arthritis by Zeuner, Rainald A., Verthelyi, Daniela, Gursel, Mayda, Ishii, Ken J., Klinman, Dennis M.

    Published in Arthritis and rheumatism (01-06-2003)
    “…Objective To examine whether systemic administration of immunostimulatory and immunosuppressive oligodeoxynucleotides (ODNs) alter host susceptibility to…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Biologics as treatment for systemic lupus: great efforts, sobering results, new challenges by Schröder, Johann O, Zeuner, Rainald A

    Published in Current drug discovery technologies (01-12-2009)
    “…Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by specific organ manifestations and the production of autoantibodies to nuclear…”
    Get more information
    Journal Article
  9. 9

    Recombinant human granulocyte colony stimulating factor in patients with systemic lupus erythematosus associated neutropenia and refractory infections by Euler, H H, Harten, P, Zeuner, R A, Schwab, U M

    Published in Journal of rheumatology (01-11-1997)
    “…To investigate whether human recombinant granulocyte colony stimulating factor (GCSF) is capable of inducing increased neutrophil granulocyte…”
    Get more information
    Journal Article
  10. 10

    High dose intravenous immunoglobulins in systemic lupus erythematosus: clinical and serological results of a pilot study by Schroeder, J O, Zeuner, R A, Euler, H H, Löffler, H

    Published in Journal of rheumatology (01-01-1996)
    “…To investigate the effect of high dose intravenous immunoglobulins (IVIG) in systemic lupus erythematosus (SLE). Twelve patients with mildly to moderately…”
    Get more information
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    High dose intravenous immunoglobulin in autoimmune rheumatic disorders by Zeuner, R A, Euler, H H, Schroeder, J O

    “…Since the effectiveness of high dose intravenous immunoglobulin (IVIg) was first demonstrated in autoimmune thrombocytopenia, IVIg has been investigated in the…”
    Get full text
    Journal Article
  15. 15

    Plasma exchange in systemic lupus erythematosus by Euler, Hans H., Zeuner, Rainald A., Schroeder, Johann O.

    Published in Transfusion science (01-06-1996)
    “…Standard treatment for severe systemic lupus erythematosus (SLE) consists of corticosteroids and immunosuppressive drugs. A number of controlled studies…”
    Get full text
    Journal Article
  16. 16

    Treatment-free remission in severe systemic lupus erythematosus following synchronization of plasmapheresis with subsequent pulse cyclophosphamide by Euler, H H, Schroeder, J O, Harten, P, Zeuner, R A, Gutschmidt, H J

    Published in Arthritis and rheumatism (01-12-1994)
    “…To investigate the effect of an intensified treatment protocol synchronizing plasmapheresis with subsequent pulse cyclophosphamide for severe systemic lupus…”
    Get more information
    Journal Article
  17. 17

    Monoclonal cryo-antifibrinogenemia by Euler, H H, Zeuner, R A, Béress, R, Gutschmidt, H J, Christophers, E, Schroeder, J O

    Published in Arthritis and rheumatism (01-06-1996)
    “…We report on a 54-year-old female patient with arthritis and a severe cold-induced leukocytoclastic vasculitis of the skin caused by a rare form of…”
    Get more information
    Journal Article